6924-71-6 Usage
Uses
Used in Chemical Synthesis:
Methyl quinoxaline-5-carboxylate is used as a key intermediate in the synthesis of more complex chemical compounds. Its stability and ability to undergo a variety of reactions make it a valuable component in the production process.
Used in Pharmaceutical Industry:
Methyl quinoxaline-5-carboxylate is used as a building block in the development of pharmaceuticals. Its chemical properties allow it to be incorporated into the structures of various drugs, contributing to their overall effectiveness and function.
Used in Dye Production:
Methyl quinoxaline-5-carboxylate is used as a component in the production of dyes. Its chemical versatility enables it to be integrated into the formulation of a wide range of colorants, enhancing their performance and applicability in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 6924-71-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,9,2 and 4 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 6924-71:
(6*6)+(5*9)+(4*2)+(3*4)+(2*7)+(1*1)=116
116 % 10 = 6
So 6924-71-6 is a valid CAS Registry Number.
6924-71-6Relevant academic research and scientific papers
Catalytic formation of ketones from unactivated esters through rhodium chelation-assisted C-O bond activation
Wang, Jingjing,Zuo, Sujing,Chen, Weiqiang,Zhang, Xinrui,Tan, Kaixin,Tian, Yun,Wang, Jianhui
, p. 8217 - 8231 (2013/09/24)
A new method for building aryl aryl ketones containing heterocyclic rings through chelation-assisted C-O bond activation catalyzed by a rhodium complex has been developed. In this reaction, methyl quinoline-8-carboxylate, methyl quinoxaline-5-carboxylate, and their derivatives were reacted with an excess amount of a substituted phenyl boronic acid in the presence of a rhodium(I) complex to give substituted phenyl(quinolin-8-yl)methanone, phenylquinoxalin-5- ylmethanone, and their derivatives in medium to high yields. The current method offers a highly favorable synthetic pathway to efficiently build related drugs with an 8-benzoylquinoline core structure. This method may prove especially valuable for medicinal chemists for the late-stage introduction of versatile ketone moieties into complex scaffolds for diversity-oriented synthetic strategies.
